added 7.44% to his stake in Forest Laboratories Inc. (NYSE:FRX
) at the average price of $34.33 on 08/21/2012, as reported in the latest insider filings by Carl Icahn
. He owns 28,323,697 shares. Forest Laboratories Inc. and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter. Forest Laboratories Inc. has a market cap of $9.09 billion; its shares were traded at around $34.66 with a P/E ratio of 11.6 and P/S ratio of 2. Forest Laboratories Inc. had an annual average earnings growth of 9.7% over the past 10 years. GuruFocus rated Forest Laboratories Inc. the business predictability rank of 4-star.
Several gurus hold positions in FRX. Richard Pzena
owns 11,128 shares as of 06/30/2012, an increase of 231.88% from the previous quarter. This position accounts for 0.0045% of the $8.56 billion portfolio of Pzena Investment Management LLC. Joel Greenblatt
owns 379,743 shares as of 06/30/2012, which accounts for 0.98% of the $1.36 billion portfolio of Gotham Capital. John Hussman
owns 350,000 shares as of 06/30/2012, which accounts for 0.23% of the $5.32 billion portfolio of Hussman Economtrics Advisors. Continue Reading »